Dividends
VALUE INVESTING IDEA RECKITT BENCKISERAnalyzing RECKITT BENCKISER under value investing prospective it comes with a discount price compared to its intrinsic value. The company keep revenue growing even with pandemic environment and growth will continue on 2021 and 2022. But this is not the main topic to highlight because future growth of the company will be based on strong investment in R&D made in 2020.
The company instead of cutting const in a difficult year focused in R&D with the highest expense amount in is history to put itself in the perfect place to be to take advantage in 2021 and 2022 from pandemic environment.
The company has already a strong position on hygiene products nd this will be the strongest pillar for future growth
From a discounted cash flow model I setted target price for 2022 and 2023 and the line that links those target is my intrinsic value line.
At same time we can see from the chart that there is a strong support area and while price is near this area we the max advantage from our investment.
Possible upside is up to 30% - 50% for an already well positioned and established business.
On top of it company pays regular, sustainable ad growing dividend.
Juiced Up Packaged Food - B&G FoodsWho would've thought a packaged food brand would rise 300% in the last year while paying over 6% dividend?
B&G Foods owns several popular grocery store food brands like: Green Giant, Cream of Wheat, Crisco, Weber, and so many more. With so many people cooking from home over the past year, BGS stock has exploded in popularity. Will this stock continue to trend up towards old highs of $50+?
I increased my position in BGS last Thursday, March 4th, after the stock price came down and hit my dotted trend line and the bottom of the envelope. Considering the current chart pattern, BGS looks like it could be at a resistance point. If BGS can break through the $31.50 resistance level, $33.30 looks to be the next resistance (the top of the envelope). If the price fails to break through the $31.50 level, look for resistance at $28 (the floor on the dotted ascending trend line).
Here are some interesting key statistics to consider:
- The 52 week low on BGS is $10.39
- $2 billion market cap
- 6.16% dividend yield (Compared to competitors: MDLZ - 2.27%, CAG - 3.05%, GIS - 3.55%, K - 3.87%)
- 15.08 P/E (Compared to competitors: MDLZ - 22.44, CAG - 15.85, GIS - 14.72, K - 16.28)
- Debt/Equity 284.79 (Compared to competitors: MDLZ - 76.11, CAG - 112.64, GIS - 147.92, K - 223.96)
- 29.61% of float is short (Compared to competitors: MDLZ - 0.97%, CAG - 3.46%, GIS - 3.91%, K - 8.25%)
While there is still a significant percentage of the float short, which raises a red flag, the brand's BGS own are household staples for many Americans, and I believe these brand's will continue to grow in popularity over the years to come. And, with a 6.16% dividend yield, this stock presents a great opportunity to earn some cash flow each quarter.
Citigroup LongHi all,
I noticed looking at a few filters on my screener that there was some high dividend yielding companies all showing good benjamin graham numbers. It was immediately obvious to me that the vast bulk of them were in the financial sector, with the narrative of most of the worlds developed populations life changed by huge degrees and the flow of money slowed for most that lending would in turn go down. I got in at $45.31 in onctober and have bought in every other month since. current total position is sitting at +22%.
My initial investment was going to be long term (10Y) but I will re-evaluate if/when we reach the top of the window shown on the chart.
KCS - A gem inside the rock
Kucoin Token (KCS), also known as Kucoin Share is a Token introduced by Kucoin Exchange - Kucoin.com
From my perspective, this coin is currently undervalued as it has many advantages compared to other cryptos.
Fundamental reviews
Strengths:
-Kucoin Bonus - a bonus scheme from Kucoin for KCS holder. Kucoin will spend 50% of the exchange daily revenue to buy KCS and payout to holders at 00:00 (GMT+0). KCS to me is like a Stock of Kucoin exchange which payout dividend for investors, not just a coin. The current payout rate is about 25% / year - much higher than any other stock. The normal dividend rate of any stock is only about 5-10% per year, so from an investor perspective, this coin should increase by 100% to have the correct value.
-Kucoin quarterly buyback and burnt - Kucoin will buy back KCS from the market and burn the coin every quarter, the next burn will happen by 25/02/2021 for the value of over 600,000 USD.
-KCS is going to get listed to 5 additional exchangers in 2021, which can help to increase the price of this coin.
Risks:
-Currently, KCS is ranked 141 at the time I'm writing this review on Coinmarketcap, the trading volume for this coin is pretty low even though this is a native token of an exchanger.
-KCS just increased price by more than 200%, which means there is a high chance that the token needs a consolidation period.
-Kucoin Exchange got hacked last year, but they have recovered all the funds and all the client gets their money back from Kucoin.
Technical analysis:
-Kucoin just broke through resistance at 1.4 & 2.3, and reach the new resistance at 3.0 USD. If the support at 2.2 can hold, there is a high chance that Kucoin can break through 3.0 and reach the next resistance at 4.5.
Recommended Trading Strategy:
-Buy at 2.2-2.3 USD, stop loss at your own risk preference (I put mine at 1,9988 )
-Take profit price: 2.98 - 4.55 - 6.15
Please add my code for signup if you want to get some KCS on kucoin: 2Qfecwv
Thank you
BQX/USD Bullish Pennant (200% Upside)BQX/USD is on an amazing run. After the $GME fiasco, many retail investors are running away from Robinhood and trying to find a new brokerage and trading platform. Voyager is one of the platforms these investors have found and they have been on a bull run since.
The ticker is consolidating at $2.50, but after this pennant is broken, it will can go on a run to over $5.00.
VZ analysisNow! is a good time to buy and hold $VZ
For 2021, Verizon expects: Service and other revenue growth of at least 2%, including total wireless service revenue growth of at least 3%; Adjusted EPS (non-GAAP) of $5.00 to $5.15;
Adjusted effective income tax rate (non-GAAP) in the range of 23 to 25%; Capital spending to be in the range of $17.5B to $18.5B.
In this 5Y DCF Growth exit model, VZ stock has an upside of at least 8%, excluding the 4.4% dividend yield (12.4% total return, 1 year).
Ex-dividend date - An end to investors' hesitation?Good evening.
Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off.
Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says
Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February.
Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021.
P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more.
Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?
XOP fractalOil prices have been on a tear lately, driven by a combination of travel recovery and inflation expectations. Oil and gas stocks have been rising along with them. (Other commodities prices are climbing as well, by the way, which bodes well for value stocks for the foreseeable future.)
Oil and gas companies still looks reasonably valued, with roughly 10-15% upside to median valuation of the last 4 years. The space still offers some of the best dividends available, even after a number of companies made dividend cuts last year. However, companies in the space are also still financially pretty weak. Free cash flow has plummeted toward zero even on some of the most secure oil majors. So there's definitely some risk.
In technical terms, I noticed that XOP looks to be making a repeating fractal pattern. If the fractal continues, then we ought to see the price rise more or less straight up from the current close of $72 to my target at about $80, before pulling back toward the trend line. Be aware that I've not traded fractals much, so I don't really know how likely this is to play out. Just posting the idea here for future reference.
Seagate Technologies bullish trend line breakSeagate Technologies has been in a correction since mid-December, but today it made a bullish break across a trend line that has held for about 4 weeks. Seagate is one of the better values in the technology space, with a dividend payout of over 4.5% and about 11% upside to its median earnings-day valuation of the last 3 years. It's a highly innovative company, averaging 26 patents per year per billion in market cap.
Sentiment for Seagate has been somewhat negative, with analysts and technicals neutral and options interest mostly on the put side. However, today's trend line break signals that sentiment is beginning to improve. We may see one or two more dips before the stock moves decisively higher, but I do think an upward move will be coming in the next few weeks.
Long Bristol Myers for 2021 and beyond- Technical w/FundamentalBristol Myers is in a great position both fundamentally and technically. Time horizon is 1-2 years.
Technical:
Ascending Triangle with Price above the 30-day and 210-day simple moving averages. This could squeeze into the previous highs set in 2018 and 2016 (~$75).
We want to see the price continue to stay above these averages as well as the trend line connecting the recent higher lows.
Fundamental:
-Recent Celgene acquisition adds $18B in revenue and diversifies BMY's product portfolio. Before the acquisition, BMY's Top 3 Drugs made up almost 75% of its total revenue. After the acquisition this same ratio is only 43%, decreasing BMY's reliance on its top 3 drugs.
-Last three years the average P/E based on operating earnings for BMY has been 14.21, and at their current price they are trading at a 9.79, suggesting they may be currently undervalued.
-Dividend of $1.92 or 3.14% yield
-21.41% Adjusted Operating Earnings growth rate
-A+ S&P credit rating
Price Target = $100-110
Long on L&T Finance....But why ?Technical Analysis
1. Close to breakout ie. R1
2. Breakout in RSI
3. EMA bullish Cross about to happen
Fundamental Analysis
* Opportunity
1. P/B ratio is low
2. Dividend Yield is good compares to peers
3. YOY Quarterly profit is Higher then peers
4. Compounded sales growth is increasing
5. Promoters' shareholding is 63.67%
6. Reserves is increasing
*Weakness
1. Company have huge borrowing
2. EPS is low compare to peers and historic data
3. Interest coverage ratio is low
** This is the right time to invest in this company.
XRP - A fundamental case for a long term bias/tradeFacts:
- SEC is suing Ripple Labs for the sale of unregistered securities
- XRP and Ripple are not the same. XRP is the coin, Ripple Labs is the company
- Unless Ripple Labs goes public, XRP it is not a security
Bullish news:
SBI, a Japanese company that has recently acquired multiple crypto exchanges in 2020 and initially invested in XRP with company SBI Ripple Asia in 2016, is interested in a crypto index that is majority XRP
SBI offers shareholders XRP as dividend payouts
SBI Ripple Asia is not being sued by the SEC
SBI Ripple Asia is very interested in using XRP as its blazing fast remittance currency, and MoneyTap (not a U.S. company) will be using it.
" Interbank transfer fees remained high in Japan and have not been changed for more than 40 years, which is unusual by international standards. "
Japan's regulatory body FSA has already declared XRP is not a security .
Bought on saleIt's 50% off compared to its intrinsic value.
It could go down further, thus the stop. It's "risky".
Out of all the tech stocks I've looked at $ CSCO has the BEST fundamentals.
High growth potential.
You probably want to wait for when it goes back up or grab some call options.
I only bought a single share. So it could go to 0 I wouldn't cry about it.
The fundamentals are there. The price doesn't make sense this low.